FIELD: medicine; pharmacology.
SUBSTANCE: composition includes effective amount of carbamazepine as active ingredient, and carbomer 71G, microcrystalline cellulose, sodium carboxymethylstarch, aerosol, and stearate salt as auxiliary ingredients. The composition is manufactured by direct pressing method, preferably in form of tablets.
EFFECT: composition stability during storage period, release profile reproducibility of active substance, satisfactory pharmacokinetic characteristics, and high strength of the tablets.
5 cl, 1 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION ELICITING ANTICONVULSANT AND PSYCHOTROPIC EFFECT AND METHOD FOR ITS PREPARING | 2003 |
|
RU2240798C1 |
ANTICONVULSANT AND PSYCHOTROPIC AGENT AND METHOD OF ITS PREPARING | 1999 |
|
RU2157212C1 |
PENTOXYPHYLLINE-BASE DRUG | 2001 |
|
RU2190408C1 |
DRUG BASED ON TETRAMETILTETRAAZOBITSIKLOOKTANDION AND METHOD FOR ITS PRODUCTION | 2012 |
|
RU2611194C2 |
PHARMACEUTICAL AGENT WITH CARDIOVASCULAR EFFECT | 2001 |
|
RU2206316C1 |
METHOD OF OBTAINING MEDICAL FORM OF TRIMETAZIDINE OF PROLONGED ACTION | 2012 |
|
RU2530558C2 |
SOLID MEDICINAL FORM OF MATRIX TYPE, WHICH HAS ANTI-INFLAMMATORY, ANALGESIC, FEBRIFUGAL ACTIVITY, WITH PROLONGED RELEASE AND METHOD OF ITS OBTAINING | 2007 |
|
RU2354358C1 |
PROLONGED ACTION PREPARATION OF DICLOFENAC SODIUM | 2002 |
|
RU2221559C1 |
MODIFIED RELEASE 6-METHYL-2-ETHYL-HYDROXYPYRIDINE SUCCINATE DOSAGE FORM | 2008 |
|
RU2411035C2 |
PHARMACEUTICAL COMPOSITION OF ANTIEPILEPTIC ACTIVITY AND METHOD OF PRODUCTION THEREOF | 2007 |
|
RU2345777C1 |
Authors
Dates
2008-12-27—Published
2007-04-05—Filed